Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction

HM Salah, A Pandey, A Soloveva… - Basic to Translational …, 2021 - jacc.org
Although there is an established bidirectional relationship between heart failure with
reduced ejection fraction and liver disease, the association between heart failure with …

Non‐alcoholic fatty liver disease‐related risk of cardiovascular disease and other cardiac complications

CD Byrne, G Targher - Diabetes, Obesity and Metabolism, 2022 - Wiley Online Library
Abstract Background/Aim Non‐alcoholic fatty liver disease (NAFLD) affects approximately
25% of the global adult population. The aim of this narrative review is to describe the …

Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals

A Mantovani, G Petracca, A Csermely, G Beatrice… - Gut, 2023 - gut.bmj.com
Objective Recent studies reported an association between non-alcoholic fatty liver disease
(NAFLD) and increased risk of new-onset heart failure (HF). However, the magnitude of the …

Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries

M Fudim, L Zhong, KV Patel, R Khera… - Journal of the …, 2021 - Am Heart Assoc
Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing
in prevalence. The independent association between NAFLD and downstream risk of HF …

Integrating liver endpoints in clinical trials of cardiovascular and kidney disease

F Zannad, AJ Sanyal, J Butler, V Miller, SA Harrison - Nature Medicine, 2024 - nature.com
The intersection of cardiovascular disease, metabolic disorders and chronic kidney disease
represents a complex clinical picture challenging healthcare systems worldwide. Metabolic …

NAFLD in cardiovascular diseases: A contributor or comorbidity?

B Chen, WHW Tang, M Rodriguez… - Seminars in liver …, 2022 - thieme-connect.com
Nonalcoholic fatty liver disease (NAFLD) and cardiovascular diseases are both highly
prevalent conditions around the world, and emerging data have shown an association …

Liver fibrosis scores and prognosis in patients with cardiovascular diseases: a systematic review and meta‐analysis

Z Yan, Y Liu, W Li, X Zhao, W Lin… - European Journal of …, 2022 - Wiley Online Library
Background In patients with nonalcoholic fatty liver disease, liver fibrosis was associated
with a higher risk of cardiovascular events. However, the relationship between liver fibrosis …

The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis

W Tucker, RL McClelland, MA Allison, M Szklo, KA Rye… - Metabolism, 2023 - Elsevier
Background Fibroblast growth factor 21 (FGF21) levels are often elevated in heart failure
(HF), although this has not been assessed using a longitudinal study design. Therefore, we …

Non-alcoholic fatty liver disease as an emerging risk factor for heart failure

RM Inciardi, A Mantovani, G Targher - Current Heart Failure Reports, 2023 - Springer
Abstract Purpose of the Review Non-alcoholic fatty liver disease (NAFLD) and heart failure
(HF) are two chronic diseases that have become important global public health problems …

High‐sensitivity C‐reactive protein is associated with heart failure hospitalization in patients with metabolic dysfunction‐associated fatty liver disease and normal left …

XD Zhou, QF Chen, G Targher, CD Byrne… - Journal of the …, 2024 - Am Heart Assoc
Background Systemic chronic inflammation plays a role in the pathophysiology of both heart
failure with preserved ejection fraction (HFpEF) and metabolic dysfunction‐associated fatty …